s.stavrianos
TL2 Member · Winnipeg, CA
Keeps a personal log and shares the numbers when they are relevant, with the measurement caveats attached.
Joined 21 March 2025 · last posted 2d
86 posts, newest first. Showing up to 150.
-
Follow-up: The retatrutide phase 2 obesity paper, read closely Replied, post #24 · Compounds › Retatrutide · 26 Jul 2026 · 5 likes post #23 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather…
-
[2026 update] Documenting an adverse event properly Replied, post #21 · Safety › Adverse events · 25 Jul 2026 · 28 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
CJC-1295 with and without DAC: what the modification does Replied, post #117 · Compounds › Secretagogues & GH axis · 20 Jul 2026 · 11 likes Why this subcategory is stricter about sourcing than most: the evidence base is weaker and that is precisely why documentation quality matters more. A supplier page…
-
Forced degradation studies: designing one that is informative Replied, post #96 · Analytics › Method validation · 11 Jul 2026 · 0 likes Accuracy: the method measures what you intend to measure. For purity methods, this is tested by spike-and-recover experiments: add a known amount of impurity to a…
-
Follow-up: Sleep quality changes during weight loss Replied, post #66 · Wellbeing › Sleep · 10 Jul 2026 · 0 likes Obstructive sleep apnoea: pre-existing OSA can worsen with weight before it improves (apnoea-hypopnoea index goes up as soft tissue inflames before weight is lost).…
-
Revisiting: What pooling buys you and what it destroys Replied, post #75 · Evidence › Meta-analyses · 1 Jul 2026 · 24 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #77 · Safety › Contraindications · 17 Jun 2026 · 0 likes I read post #75 twice before replying, because I had assumed the opposite. Medullary thyroid carcinoma (personal or family history) or multiple endocrine neoplasia type…
-
Second pass at: Programming during a large energy deficit Replied, post #30 · Nutrition & Training › Resistance training · 16 Jun 2026 · 26 likes Intensity: using weights that allow 6 to 12 reps before fatigue is a reasonable range for preserving muscle. Heavier weights with lower reps can work but require more…
-
Why this subcategory is stricter about sourcing than most Replied, post #42 · Compounds › Secretagogues & GH axis · 13 Jun 2026 · 2 likes Coming back to post #40, because the follow-up matters more than the original answer. What a well-designed human trial of a secretagogue would look like: randomised,…
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Started this topic · Sourcing › Independent verification · 3 Jun 2026 · 38 likes On the subject in the title: Interpreting a result that disagrees with the supplier's certificate Working notes rather than a conclusion. Structured report rather than…
-
GLP-1 receptor distribution: central and peripheral Replied, post #58 · Pharmacology › Receptor biology · 28 May 2026 · 0 likes Pharmacological class effects: all GLP-1 agonists slow gastric emptying and suppress appetite. Those are class effects, not unique to one compound. Effects that differ…
-
Why the titration planner refuses to produce a schedule below a floor Replied, post #77 · Data & Tools › Calculators · 23 May 2026 · 3 likes Mass error checking: enter your observed mass and theoretical mass and check whether the difference in ppm is within reasonable bounds for your instrument. Useful…
-
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #58 · Compounds › Repair & healing peptides · 22 May 2026 · 17 likes Picking up post #55: that is the part I would want checked first. Stability of BPC-157 in solution: what has been measured in published work covers specific…
-
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #47 · Practice › Interactions · 20 May 2026 · 12 likes Separation timing versus clinically important interaction: a separation timing inconvenience (taking one medication 2 hours before or after another) is not the same as…
-
Official shortage notices and what they authorise Replied, post #34 · Access › Shortages · 5 May 2026 · 0 likes Picking up post #31: that is the part I would want checked first. Supply interruptions: official shortage notices are published by regulatory agencies. That is the…
-
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #123 · Analytics › Mass spectrometry · 28 Apr 2026 · 21 likes What mass accuracy establishes: the measured mass is consistent with a specific composition. What it does not establish: purity, sequence order, stereochemistry, or the…
-
Injection discomfort: needle gauge, volume, temperature, technique Replied, post #54 · Practice › Administration · 20 Apr 2026 · 19 likes On post #50 — agreed on the reasoning, with one qualification. Injecting into an area that has become firm: lipohypertrophy — thickened fatty tissue from repeated…
-
Revisiting: Absolute versus relative contraindications Replied, post #68 · Safety › Contraindications · 17 Apr 2026 · 0 likes post #67 is right about the mechanism and I think understates the practical bit. Pregnancy: these compounds are not approved for pregnancy. The potential risks outweigh…
-
Adolescents: a distinct evidence base — one year on Replied, post #87 · Clinical › Special populations · 16 Apr 2026 · 2 likes This follows post #84 rather than contradicting it. Pregnancy and planning: these compounds are not approved for use in pregnancy. Planning windows (how long to wait…
-
Spike-and-recover accuracy for a peptide assay Replied, post #112 · Analytics › Method validation · 10 Apr 2026 · 6 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Reference intervals: how they are constructed and why one in twenty flags Replied, post #60 · Clinical › Bloodwork · 6 Mar 2026 · 0 likes Coming back to post #58, because the follow-up matters more than the original answer. Biological variation: the person-to-person variation in a biomarker for a healthy…
-
Realistic expectations for strength while losing weight quickly Replied, post #68 · Nutrition & Training › Resistance training · 5 Mar 2026 · 9 likes Maintenance is the goal: preserving lean mass and strength during weight loss is the goal of resistance training in this context, not building new muscle. That goal is…
-
Follow-up: Search filters: what is missing Replied, post #38 · Meta › Site feedback · 21 Feb 2026 · 28 likes Accessibility: screen readers, keyboard navigation, contrast, font size — if something is not accessible to you, report it. Accessibility matters.
-
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #3 · Evidence › Journal club · 18 Feb 2026 · 0 likes Session format: read the paper before posting. The discussion is much better when everyone has. Start with the estimand and population, then methods, then results, then…
-
Mass error in ppm: the arithmetic and the caveat Replied, post #71 · Analytics › Mass spectrometry · 14 Feb 2026 · 2 likes Picking up post #68: that is the part I would want checked first. Resolution: "high resolution" commonly means
-
Revisiting: Review: an evidence digest and the citation check that delayed it Replied, post #57 · Documentation › Doc review · 5 Feb 2026 · 10 likes Fact-checking: if you see a factual claim in a maintained page that you have evidence contradicts, post the evidence here. The maintainer will review and correct if you…
-
Coming back to: Semaglutide in people without diabetes: what the evidence base looks like Replied, post #29 · Compounds › Semaglutide · 3 Feb 2026 · 0 likes The opalescent appearance in semaglutide solutions is occasionally noted and the mechanism is unclear. It does not appear to correlate with product failure in practice.…
-
EU-wide position versus national implementation — what changed since Replied, post #15 · Regional › European Union · 1 Feb 2026 · 2 likes Netherlands: CBG-MEB implements framework. GPs are first point of contact. Insurance coverage for weight management is conditional on structured lifestyle programme…
-
Trifluoroacetate content and its consequences Replied, post #62 · Analytics › Impurities & related substances · 1 Feb 2026 · 19 likes This follows post #59 rather than contradicting it. Dimer and higher-order multimers: two or more peptide molecules bonded together. They appear at double the mass and…
-
Can a home kit substitute for a laboratory report? A careful no Replied, post #122 · Analytics › Home & field testing · 31 Jan 2026 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
[2026 update] Evidence quality in the secretagogue literature: an honest assessment Replied, post #11 · Compounds › Secretagogues & GH axis · 15 Jan 2026 · 11 likes Evidence quality in the secretagogue literature is honestly weaker than in the incretin literature. Large randomised controlled trials are rare. Most evidence is…
-
Storing lyophilised material long term: what governs the shelf life Replied, post #18 · Practice › Storage & stability · 7 Jan 2026 · 8 likes This follows post #15 rather than contradicting it. Dating prepared solutions: write the date reconstitution on the vial in permanent marker. If you later need to know…
-
Coming back to: Payment mechanics and the recovery options that do not exist Replied, post #2 · Sourcing › Payments · 6 Dec 2025 · 0 likes Bank transfer and finality: once a bank transfer is sent, it is final. The money is gone. There is no recourse with the bank if the supplier disappears. That is why…
-
MHRA statements, read directly Replied, post #39 · Regional › UK & Ireland · 28 Nov 2025 · 15 likes This follows post #36 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #38 · Compounds › Semaglutide · 26 Nov 2025 · 31 likes Coming back to post #36, because the follow-up matters more than the original answer. Semaglutide versus liraglutide in STEP 8: semaglutide produced greater weight…
-
[2026 update] Long-time reader, first-time poster Replied, post #22 · Lounge › Introductions · 2 Nov 2025 · 0 likes This follows post #19 rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add…
-
Journal club: how we handle discontinuation in obesity trials — what changed since Replied, post #13 · Evidence › Journal club · 29 Oct 2025 · 1 like Session format: read the paper before posting. The discussion is much better when everyone has. Start with the estimand and population, then methods, then results, then…
-
How the published trials escalated, tabulated side by side — does this still hold? Replied, post #3 · Practice › Dosing & titration · 28 Oct 2025 · 30 likes post #2 is right about the mechanism and I think understates the practical bit. Micro-titration: the concept of increments smaller than the labelled steps. It has no…
-
Anxiety in the first weeks: drug, situation, or both — what changed since Replied, post #38 · Wellbeing › Mental health · 16 Oct 2025 · 26 likes Mood and anxiety: mood changes and anxiety are reported by some people. Baseline mental health status matters for risk. Someone with a history of depression should plan…
-
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #38 · Start Here › Welcome · 15 Oct 2025 · 0 likes On the reading order question specifically: start with the how-to-ask materials in this category, then read the one to three subcategories where your main questions…
-
New subcategory: rationale and scope Replied, post #9 · Meta › Announcements · 12 Oct 2025 · 3 likes Picking up post #6: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
Airline travel with a temperature-sensitive injectable Replied, post #5 · Devices › Cold chain · 30 Sep 2025 · 3 likes Temperature excursions: brief excursions above 8 °C are tolerable for most compounds. Hours to a day at room temperature is usually acceptable. Days to weeks at room…
-
Detection wavelength and why 214 nm and 280 nm disagree Replied, post #55 · Analytics › HPLC & UHPLC · 28 Sep 2025 · 11 likes Gradient slope is the single biggest driver of apparent purity differences. A shallower gradient over a longer run resolves more impurities and gives a higher purity…
-
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #115 · Compounds › Retatrutide · 22 Sep 2025 · 0 likes Triple agonism: is the effect additive, synergistic, or neither? A phase 2 comparison of tirzepatide (dual) to retatrutide (triple) would answer that question. The…
-
Tracking that stops updating and then resumes — the long version Replied, post #13 · Sourcing › Logistics · 9 Sep 2025 · 6 likes Documentation after arrival: photograph the parcel and its contents on arrival. If something later turns out wrong (damage, loss, wrong item) you have evidence of the…
-
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #57 · Evidence › Journal club · 18 Aug 2025 · 15 likes Worth separating two things that post #53 runs together. PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not efficacy. Non-inferiority…
-
Are there stupid questions here? A staff answer, at length Replied, post #81 · Start Here › Welcome · 17 Aug 2025 · 26 likes Nothing here requires expertise. The experienced members here got that way by posting questions, not by knowing the answer before they showed up. If you know something…
-
Thyroid function tests during substantial weight change Replied, post #29 · Clinical › Bloodwork · 13 Aug 2025 · 25 likes Analytical imprecision: any measurement has an error margin. A small difference in consecutive tests is usually measurement noise, not a real change. Knowing the…
-
Are there stupid questions here? A staff answer, at length Replied, post #64 · Start Here › Welcome · 12 Aug 2025 · 0 likes Picking up post #61: that is the part I would want checked first. Your introduction is well framed. You have given enough context that people can actually answer. That…
-
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #75 · Access › Insurance & coverage · 10 Aug 2025 · 12 likes Appeals process: unemotional prose, the criterion quoted verbatim, evidence mapped to it point by point, dates, and nothing else. Describing how the decision affected…
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #94 · Compounds › Repair & healing peptides · 7 Aug 2025 · 0 likes I read post #92 twice before replying, because I had assumed the opposite. Publication patterns in the BPC-157 literature: a large proportion of the evidence comes from…
-
Journal club: indirect comparison between two programmes, defended and attacked — one… Replied, post #18 · Evidence › Journal club · 2 Jul 2025 · 0 likes SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective physiological endpoint. Notable because soft endpoints are avoided. Two…
-
Reading an MS report that only gives you a single number Replied, post #113 · Analytics › Mass spectrometry · 20 Jun 2025 · 6 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Coming back to: When "no data" is the complete and final answer Replied, post #13 · Compounds › Other compounds · 14 Jun 2025 · 12 likes AOD-9604 is a fragment of human growth hormone and has been discussed as a potential weight-loss agent based on theoretical mechanism. The fragment hypothesis — that…
-
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #49 · Evidence › Trials · 10 Jun 2025 · 0 likes Intent-to-treat versus per-protocol: ITT includes everyone assigned regardless of whether they took the drug. Per-protocol includes only those who completed it as…
-
Pre-registering a personal experiment, seriously Replied, post #4 · Research Methods › N-of-1 designs · 25 May 2025 · 0 likes Generalisability: a robust n-of-1 result applies to you. It does not tell you much about whether the effect generalises to others similar to you, much less to people…
-
Pregnancy as an absolute contraindication Replied, post #26 · Safety › Contraindications · 17 May 2025 · 15 likes This follows post #23 rather than contradicting it. Pregnancy: these compounds are not approved for pregnancy. The potential risks outweigh potential benefits. Planning…
-
Airline travel with a temperature-sensitive injectable — what changed since Replied, post #25 · Devices › Cold chain · 8 May 2025 · 22 likes Freeze-thaw: some peptides tolerate freezing; others do not. Check your compound's labelling. Generally, repeated freeze-thaw is worse than single freeze-thaw.
-
Why pulsatile secretion matters for interpreting secretagogue claims — a second dataset Replied, post #64 · Compounds › Secretagogues & GH axis · 4 May 2025 · 0 likes post #63 is right about the mechanism and I think understates the practical bit. Pulsatile secretion matters because growth hormone is secreted in pulses, not…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #29 · Sourcing › Independent verification · 30 Apr 2025 · 14 likes Interpreting a result: a purity figure is one measurement on one vial on one day. Agreement across two services is much stronger. A single high number does not…
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #81 · Compounds › Semaglutide · 17 Apr 2025 · 15 likes Picking up post #78: that is the part I would want checked first. The STEP programme populations were selected: enrollment criteria required baseline body mass index…
-
Introducing myself and asking whether my planned first topic belongs anywhere Replied, post #19 · Start Here › Welcome · 19 Mar 2025 · 0 likes post #18 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather…
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #136 · Sourcing › Vendor reports · 19 Mar 2025 · 0 likes Disputed records: when a result disagreed and was not explained, the record says disputed and stays that way. We do not remove inconvenient history; we document it.
-
Research-use-only status: what it means legally and practically — a second dataset Replied, post #114 · Compounds › Other compounds · 14 Mar 2025 · 1 like Picking up post #111: that is the part I would want checked first. Distinguishing marketed research compounds from true chemical synthesis: some online suppliers sell…
-
Scheduled maintenance and what will be unavailable Replied, post #72 · Meta › Announcements · 14 Mar 2025 · 1 like I read post #70 twice before replying, because I had assumed the opposite. Feedback to announcements: if you have feedback on an announced change (not a question, but…
-
Transit times by route, from a logged dataset — the long version Replied, post #67 · Sourcing › Logistics · 6 Mar 2025 · 7 likes post #66 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #33 · Sourcing › Regulatory · 28 Feb 2025 · 16 likes Off-label use and medical practice: clinicians can prescribe approved medications off-label under some circumstances. That is different from research-use-only…
-
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #102 · Data & Tools › Calculators · 23 Feb 2025 · 26 likes Coming back to post #100, because the follow-up matters more than the original answer. The calculators maintained on this site are open-source and verifiable. They are…
-
Adjudicated events and why the definition matters — the long version Replied, post #16 · Evidence › Trials · 19 Feb 2025 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Second pass at: Regression to the mean in progress reports Replied, post #56 · Research Methods › Statistics · 15 Feb 2025 · 0 likes On post #52 — agreed on the reasoning, with one qualification. Relative risk and odds ratios: both compare the rate in one group to the rate in another. Relative risk…
-
Follow-up: What other technical communities get right that we do not Replied, post #17 · Lounge › Off topic · 14 Feb 2025 · 0 likes This follows post #14 rather than contradicting it. Politics and public policy: healthcare policy that affects access to these compounds is relevant here. Partisan…
-
Coming back to: Reading a meta-analysis you disagree with, fairly Replied, post #32 · Evidence › Meta-analyses · 11 Feb 2025 · 0 likes Inclusion and exclusion criteria: a meta-analysis is only as good as its inclusion criteria. If the criteria are too broad, apples and oranges get pooled. If they are…
-
Protein density versus volume when you cannot eat much Replied, post #81 · Nutrition & Training › Protein & intake · 6 Feb 2025 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #112 · Evidence › Journal club · 1 Feb 2025 · 17 likes SOUL (N Engl J Med 2025): Oral semaglutide cardiovascular outcomes. Extends the cardiovascular evidence to the oral formulation. Note that oral bioavailability is lower…
-
Checking someone else's arithmetic: a worked example thread Replied, post #18 · Practice › Reconstitution · 30 Jan 2025 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #71 · Data & Tools › Calculators · 30 Jan 2025 · 9 likes Storage lookup: which conditions (temperature, time) are you considering storing in, and how much stability loss is expected? The calculator gives a rough estimate…
-
Recovery when intake is low: what to cut first Replied, post #41 · Nutrition & Training › Resistance training · 12 Jan 2025 · 0 likes Deload weeks: periodic weeks (every 4 to 8 weeks) with reduced volume and intensity can help with recovery and sometimes reveal strength gains that got obscured by…
-
Coming back to: Recording a dissent on a document rather than suppressing it Replied, post #23 · Documentation › Doc review · 9 Jan 2025 · 7 likes Evidence synthesis requests: if you think a page should summarise the state of evidence on a question, and you think the information exists but is scattered, suggest…
-
A page that has drifted out of date and needs a maintainer Replied, post #32 · Documentation › Wiki requests · 24 Nov 2024 · 7 likes Format suggestions: if you think a maintained page could be clearer in its presentation (different section structure, different examples, added graphics) suggest the…
-
Injection-site reactions: describing them precisely enough to be useful Replied, post #16 · Practice › Side effects · 21 Nov 2024 · 29 likes On post #12 — agreed on the reasoning, with one qualification. Lean mass loss: the rate of lean tissue loss depends on protein intake, resistance training volume, and…
-
EMA product information as a primary source — does this still hold? Replied, post #140 · Regional › European Union · 18 Nov 2024 · 22 likes This follows post #137 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
Choosing which test to pay for, given a fixed budget — does this still hold? Replied, post #22 · Sourcing › Independent verification · 6 Nov 2024 · 8 likes post #21 is right about the mechanism and I think understates the practical bit. Medutest: combined purity and identity reporting. Appears throughout vendor…
-
Blind submission and why it changes minds Replied, post #90 · Sourcing › Independent verification · 17 Oct 2024 · 0 likes post #89 answers the question as asked. The question underneath it is different. Repeat testing: if you want to verify the same lot a second time, testing with a…
-
PIONEER 6 cardiovascular safety, read as a safety trial rather than an efficacy one —… Replied, post #22 · Compounds › Oral incretins · 19 Sep 2024 · 11 likes Dose numbers for oral formulations are not comparable to injectable ones. The 14 mg oral dose is not equivalent to any injectable dose in the traditional comparison…
-
Why a preprint's supplementary material is often the best part Replied, post #18 · Evidence › Preprints · 10 Sep 2024 · 0 likes I read post #16 twice before replying, because I had assumed the opposite. How to cite a preprint: author last name, first initial, et al. Title. Server name…
-
Coming back to: Pricing far outside the range, in either direction Replied, post #12 · Sourcing › Red flags · 26 Jul 2024 · 4 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…